When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis

Glucocorticoid-induced osteoporosis (GIOP) leads to fractures in up to 40% of patients with chronic glucocorticoid (GC) therapy when left untreated. GCs rapidly increase fracture risk, and thus many patients with anticipated chronic GC exposures should start anti-osteoporosis pharmacotherapy to prev...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayes, Kaleen N., Baschant, Ulrike, Hauser, Barbara, Burden, Andrea M., Winter, Elizabeth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715727/
https://www.ncbi.nlm.nih.gov/pubmed/34975756
http://dx.doi.org/10.3389/fendo.2021.782118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715727/
https://www.ncbi.nlm.nih.gov/pubmed/34975756
http://dx.doi.org/10.3389/fendo.2021.782118

Ejemplares similares